{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:58Z","timestamp":1777984378428,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hunan Health Commission Scientific Research Project","award":["20256925"],"award-info":[{"award-number":["20256925"]}]},{"name":"Natural Scientific Foundation of China","award":["82171916"],"award-info":[{"award-number":["82171916"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02004-1","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:13:20Z","timestamp":1770880400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor stroma ratio-based radiomics model for predicting platinum resistance and prognosis in epithelial ovarian cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Wang","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hucheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"5","key":"2004_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol. 2024;21(5):389\u2013400.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2004_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"2004_CR3","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1136\/ijgc-2022-004249","volume":"33","author":"AM Perrone","year":"2023","unstructured":"Perrone AM, Coada CA, Ravegnini G, De Leo A, Damiano G, De Crescenzo E, et al. Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma. Int J Gynecol Cancer. 2023;33(8):1270\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"2004_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","volume":"4","author":"PA Konstantinopoulos","year":"2023","unstructured":"Konstantinopoulos PA, Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nat Cancer. 2023;4(9):1239\u201357.","journal-title":"Nat Cancer"},{"issue":"2","key":"2004_CR5","doi-asserted-by":"publisher","first-page":"e240407","DOI":"10.1001\/jamanetworkopen.2024.0407","volume":"7","author":"E Lou","year":"2024","unstructured":"Lou E, Clemente V, Grube M, Svedbom A, Nelson AC, Blome F, et al. Tumor-stroma proportion to predict chemoresistance in patients with ovarian cancer. JAMA Netw Open. 2024;7(2):e240407.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2004_CR6","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.3390\/curroncol31070283","volume":"31","author":"B Garlisi","year":"2024","unstructured":"Garlisi B, Lauks S, Aitken C, Ogilvie LM, Lockington C, Petrik D, et al. The complex tumor microenvironment in ovarian cancer: therapeutic challenges and opportunities. Curr Oncol. 2024;31(7):3826\u201344.","journal-title":"Curr Oncol"},{"issue":"1","key":"2004_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12943-022-01670-1","volume":"21","author":"M Xu","year":"2022","unstructured":"Xu M, Zhang T, Xia R, Wei Y, Wei X. Targeting the tumor stroma for cancer therapy. Mol Cancer. 2022;21(1):208.","journal-title":"Mol Cancer"},{"key":"2004_CR8","doi-asserted-by":"publisher","first-page":"216894","DOI":"10.1016\/j.canlet.2024.216894","volume":"591","author":"M El-Tanani","year":"2024","unstructured":"El-Tanani M, Rabbani SA, Babiker R, Rangraze I, Kapre S, Palakurthi SS, et al. Unraveling the tumor microenvironment: insights into cancer metastasis and therapeutic strategies. Cancer Lett. 2024;591:216894.","journal-title":"Cancer Lett"},{"issue":"7","key":"2004_CR9","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang D, Liu J, Qian H, Zhuang Q. Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp Mol Med. 2023;55(7):1322\u201332.","journal-title":"Exp Mol Med"},{"issue":"2","key":"2004_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2021.12.023","volume":"185","author":"T Risom","year":"2022","unstructured":"Risom T, Glass DR, Averbukh I, Liu CC, Baranski A, Kagel A, et al. Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma. Cell. 2022;185(2):299-310 e218.","journal-title":"Cell"},{"issue":"4","key":"2004_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3892\/ol.2025.14936","volume":"29","author":"A Shang","year":"2025","unstructured":"Shang A, Yu P, Li L, He G, Xu J. Tumor\u2011stroma ratio as a clinical prognostic factor in colorectal carcinoma: a meta\u2011analysis of 7,934 patients. Oncol Lett. 2025;29(4):190.","journal-title":"Oncol Lett"},{"issue":"1","key":"2004_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13058-025-02017-6","volume":"27","author":"S Heydari","year":"2025","unstructured":"Heydari S, Tajik F, Safaei S, Kamani F, Karami B, Dorafshan S, et al. The association between tumor-stromal collagen features and the clinical outcomes of patients with breast cancer: a systematic review. Breast Cancer Res. 2025;27(1):69.","journal-title":"Breast Cancer Res"},{"key":"2004_CR13","doi-asserted-by":"crossref","unstructured":"Pyo JS, Kim NY, Min KW, Kang DW. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors. Medicina (Kaunas). 2023;59(7):1258.","DOI":"10.3390\/medicina59071258"},{"issue":"5","key":"2004_CR14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s00535-017-1379-1","volume":"53","author":"C Peng","year":"2018","unstructured":"Peng C, Liu J, Yang G, Li Y. The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system. J Gastroenterol. 2018;53(5):606\u201317.","journal-title":"J Gastroenterol"},{"key":"2004_CR15","doi-asserted-by":"publisher","unstructured":"van Wagensveld L, Walker C, Hahn K, Sanders J, Kruitwagen R, van der Aa M, et al. The prognostic value of tumor-stroma ratio and a newly developed computer-aided quantitative analysis of routine H&E slides in high-grade serous ovarian cancer. Res Sq. 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-3511087\/v1.","DOI":"10.21203\/rs.3.rs-3511087\/v1"},{"issue":"1","key":"2004_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13244-023-01556-w","volume":"14","author":"P Woznicki","year":"2023","unstructured":"Woznicki P, Laqua FC, Al-Haj A, Bley T, Baessler B. Addressing challenges in radiomics research: systematic review and repository of open-access cancer imaging datasets. Insights Imaging. 2023;14(1):216.","journal-title":"Insights Imaging"},{"issue":"1","key":"2004_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/med.21846","volume":"42","author":"J Guiot","year":"2022","unstructured":"Guiot J, Vaidyanathan A, Deprez L, Zerka F, Danthine D, Frix AN, et al. A review in radiomics: making personalized medicine a reality via routine imaging. Med Res Rev. 2022;42(1):426\u201340.","journal-title":"Med Res Rev"},{"issue":"6","key":"2004_CR18","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1007\/s00261-020-02820-z","volume":"46","author":"S Nougaret","year":"2021","unstructured":"Nougaret S, McCague C, Tibermacine H, Vargas HA, Rizzo S, Sala E. Radiomics and radiogenomics in ovarian cancer: a literature review. Abdom Radiol. 2021;46(6):2308\u201322.","journal-title":"Abdom Radiol"},{"issue":"1","key":"2004_CR19","first-page":"77","volume":"11","author":"S Zeng","year":"2024","unstructured":"Zeng S, Wang XL, Yang H. Radiomics and radiogenomics: extracting more information from medical images for the diagnosis and prognostic prediction of ovarian cancer. Mil Med Res. 2024;11(1):77.","journal-title":"Mil Med Res"},{"issue":"2","key":"2004_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.acra.2024.09.001","volume":"32","author":"X Huang","year":"2025","unstructured":"Huang X, Huang Y, Liu K, Zhang F, Zhu Z, Xu K, et al. Intratumoral and peritumoral radiomics for predicting the prognosis of high-grade serous ovarian cancer patients receiving platinum-based chemotherapy. Acad Radiol. 2025;32(2):877\u201387.","journal-title":"Acad Radiol"},{"issue":"6","key":"2004_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s43018-022-00388-9","volume":"3","author":"KM Boehm","year":"2022","unstructured":"Boehm KM, Aherne EA, Ellenson L, Nikolovski I, Alghamdi M, Vazquez-Garcia I, et al. Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer. Nat Cancer. 2022;3(6):723\u201333.","journal-title":"Nat Cancer"},{"key":"2004_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcancer.2021.08.011","volume":"77","author":"C Marchetti","year":"2021","unstructured":"Marchetti C, De Felice F, Romito A, Iacobelli V, Sassu CM, Corrado G, et al. Chemotherapy resistance in epithelial ovarian cancer: mechanisms and emerging treatments. Semin Cancer Biol. 2021;77:144\u201366.","journal-title":"Semin Cancer Biol"},{"key":"2004_CR23","doi-asserted-by":"crossref","unstructured":"Macis C, Santoro M, Zybin V, Di Costanzo S, Coada CA, Dondi G, De Iaco P, Perrone AM, Strigari L. A Convolutional Neural Network Tool for Early Diagnosis and Precision Surgery in Endometriosis-Associated Ovarian Cancer. Appl Sci. 2025;15(6):3070.","DOI":"10.3390\/app15063070"},{"issue":"7","key":"2004_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00432-025-06253-3","volume":"151","author":"HJ Meyer","year":"2025","unstructured":"Meyer HJ, Leonhardi J, Hohn AK, Kabbani N, Zimmermann S, Borggrefe J, et al. Associations between MRI radiomics analysis and tumor-micro milieu in uterine cervical cancer. J Cancer Res Clin Oncol. 2025;151(7):219.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2004_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.radonc.2022.02.020","volume":"169","author":"J Muller","year":"2022","unstructured":"Muller J, Leger S, Zwanenburg A, Suckert T, Luhr A, Beyreuther E, et al. Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting. Radiother Oncol. 2022;169:96\u2013104.","journal-title":"Radiother Oncol"},{"issue":"2","key":"2004_CR26","doi-asserted-by":"publisher","first-page":"201001","DOI":"10.1016\/j.omton.2025.201001","volume":"33","author":"M Madill","year":"2025","unstructured":"Madill M, Aggarwal A, Madabhushi A, Erickson BK, Nelson AC, Lou E, et al. Quantitative and qualitative metrics of tumor stroma in predicting ovarian cancer outcomes and expansion of its study with AI-based tools. Molecular Therapy Oncology. 2025;33(2):201001.","journal-title":"Molecular Therapy Oncology"},{"issue":"6","key":"2004_CR27","doi-asserted-by":"publisher","first-page":"105104","DOI":"10.1016\/j.esmoop.2025.105104","volume":"10","author":"L Collet","year":"2025","unstructured":"Collet L, Noel JC, Catteau X, Ardin M, Berthet J, Ghamry-Barrin S, et al. Tumor-stroma proportion on primary tumor as a prognostic biomarker in advanced ovarian cancer patients receiving chemo-immunotherapy as first-line therapy: analyses from the NeoPembrOV\/GINECO phase II randomized trial. ESMO Open. 2025;10(6):105104.","journal-title":"ESMO Open"},{"issue":"2","key":"2004_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41571-021-00560-7","volume":"19","author":"K Bera","year":"2022","unstructured":"Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2022;19(2):132\u201346.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2004_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41747-018-0068-z","volume":"2","author":"S Rizzo","year":"2018","unstructured":"Rizzo S, Botta F, Raimondi S, Origgi D, Fanciullo C, Morganti AG, et al. Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp. 2018;2(1):36.","journal-title":"Eur Radiol Exp"},{"issue":"4","key":"2004_CR30","doi-asserted-by":"publisher","first-page":"e230437","DOI":"10.1148\/ryai.230437","volume":"6","author":"N Horvat","year":"2024","unstructured":"Horvat N, Papanikolaou N, Koh DM. Radiomics beyond the hype: a critical evaluation toward oncologic clinical use. Radiol Artif Intell. 2024;6(4):e230437.","journal-title":"Radiol Artif Intell"},{"issue":"5","key":"2004_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.21147\/j.issn.1000-9604.2021.05.03","volume":"33","author":"C Lu","year":"2021","unstructured":"Lu C, Shiradkar R, Liu Z. Integrating pathomics with radiomics and genomics for cancer prognosis: a brief review. Chin J Cancer Res. 2021;33(5):563\u201373.","journal-title":"Chin J Cancer Res"},{"issue":"2","key":"2004_CR32","first-page":"127","volume":"69","author":"WL Bi","year":"2019","unstructured":"Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127\u201357.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2004_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/cancers13030573","volume":"13","author":"S Rizzo","year":"2021","unstructured":"Rizzo S, Manganaro L, Dolciami M, Gasparri ML, Papadia A, Del Grande F. Computed tomography based radiomics as a predictor of survival in ovarian cancer patients: a systematic review. Cancers (Basel). 2021;13(3):573.","journal-title":"Cancers (Basel)"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02004-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02004-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02004-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:19:15Z","timestamp":1773829155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02004-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2004"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02004-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7809452\/v1","asserted-by":"object"}]},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Review Committee of Hunan Cancer Hospital (KYZY2024024) in accordance with the Declaration of Helsinki. Given the retrospective nature of the study, the need for informed consent from the included patients was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}